Cigna Group (CI) to Release Earnings on Thursday

Cigna Group (NYSE:CI) is expected to announce its Q4 2025 results before the market opens on Thursday, February 5th. Analysts expect Cigna Group to post earnings of $7.90 per share and revenue of $69.5253 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same quarter in the previous year, the company earned $7.51 EPS. The company’s quarterly revenue was up 9.5% on a year-over-year basis. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Price Performance

Cigna Group stock opened at $272.68 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The firm has a market capitalization of $72.84 billion, a PE ratio of 12.03, a P/E/G ratio of 0.95 and a beta of 0.26. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm’s 50-day simple moving average is $274.62 and its 200 day simple moving average is $284.95.

Insider Transactions at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.70% of the company’s stock.

Institutional Trading of Cigna Group

Hedge funds and other institutional investors have recently modified their holdings of the business. Measured Wealth Private Client Group LLC acquired a new position in Cigna Group in the third quarter worth approximately $56,000. Johnson Financial Group Inc. increased its position in Cigna Group by 445.9% in the 3rd quarter. Johnson Financial Group Inc. now owns 202 shares of the health services provider’s stock worth $58,000 after buying an additional 165 shares during the period. WFA of San Diego LLC bought a new position in Cigna Group during the second quarter worth $99,000. Sunbelt Securities Inc. raised its position in shares of Cigna Group by 180.5% during the third quarter. Sunbelt Securities Inc. now owns 488 shares of the health services provider’s stock valued at $141,000 after buying an additional 314 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new position in Cigna Group in the 2nd quarter valued at approximately $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CI. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. The Goldman Sachs Group dropped their price objective on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company decreased their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $330.36.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.